Home » Topics » Regulatory » Patents

Patents
RSS

Endothelin antagonists part of Fujisawa's pipeline

July 12, 1996

Na+/K+-ATPase inhibitors revealed by Sigma-Tau

July 12, 1996

Torii and Hisamitsu disclose elastase inhibitors

July 12, 1996

Novel 5-lipoxygenase inhibitors described by Pfizer

July 12, 1996

NOS inhibitors from Merck & Co.

July 12, 1996

Potential CNS disorders treatment from Janssen

July 12, 1996

Biphenyl iodinated derivatives for X-ray diagnosis from Bracco

July 12, 1996

Aryloxypropanolamine beta3-adrenoceptor agnoists from Bristol-Myers Squibb

July 12, 1996

Cathepsin B and L inhibitors in Fujisawa's pipeline

July 12, 1996

Multidrug resistance modifiers from Vertex

July 12, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...